Karuna Therapeutics, Inc. Common Stock
KRTX
KRTX was delisted on the 15th of March, 2024.
132 hedge funds and large institutions have $1.56B invested in Karuna Therapeutics, Inc. Common Stock in 2020 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 49 increasing their positions, 40 reducing their positions, and 21 closing their positions.
23% more repeat investments, than reductions
Existing positions increased: 49 | Existing positions reduced: 40
14% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 21
2% more funds holding
Funds holding: 130 → 132 (+2)
25% less capital invested
Capital invested by funds: $2.08B → $1.56B (-$528M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
58% less call options, than puts
Call options by funds: $2.13M | Put options by funds: $5.05M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Viking Global Investors
Stamford,
Connecticut
|
+$56.6M |
| 2 |
Norges Bank
Oslo,
Norway
|
+$15M |
| 3 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
+$14.3M |
| 4 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
+$10.9M |
| 5 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$10.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity International
Hamilton,
Bermuda
|
-$19.4M |
| 2 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$18.3M |
| 3 |
Invesco
Atlanta,
Georgia
|
-$12.4M |
| 4 |
LCM
Laurion Capital Management
New York
|
-$5.98M |
| 5 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$5.5M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CL
151
CSS LLC
Chicago,
Illinois
| – | -$56K | -500 | Closed |
|
152
Skandinaviska Enskilda Banken (SEB)
Stockholm,
Sweden
| – | -$45K | -400 | Closed |
|
|
PCG
153
Private Capital Group
West Hartford,
Connecticut
| – | -$1K | -10 | Closed |
|
KRTX Hedge Fund Activity: Q3 2020 in Review
132 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in Karuna Therapeutics, Inc. Common Stock (KRTX) for Q3 2020, worth a combined $1.56B — down 25% from $2.08B a quarter earlier.
Buyers outnumbered sellers: 24 funds opened new KRTX positions and 21 closed out — a net gain of 3 holders — while 49 added to existing stakes and 40 trimmed.
The largest buyer was Viking Global Investors, opening a new position worth an estimated $56.6M. The largest seller was Fidelity International, cutting an estimated $19.4M.
- 132 institutional investors held Karuna Therapeutics, Inc. Common Stock (KRTX) as of Q3 2020, up from 130 in Q2 2020.
- Funds reported $1.56B of Karuna Therapeutics, Inc. Common Stock stock for Q3 2020, down 25% quarter-over-quarter.
- 24 funds opened new Karuna Therapeutics, Inc. Common Stock positions in Q3 2020 and 21 closed out, a net change of +3 holders.
- The largest Karuna Therapeutics, Inc. Common Stock buyer in Q3 2020 was Viking Global Investors, an estimated $56.6M added.
- The largest Karuna Therapeutics, Inc. Common Stock seller in Q3 2020 was Fidelity International, an estimated $19.4M sold.
Based on aggregated 13F filings for Q3 2020.